Chimeric Antigen Receptor T-Cells: The Future Is Now

The immune system acting via cancer immune-surveillance is considered a potential target for improving outcomes among some malignancies. The ability to harness immune cells, engineer them and educate them to target cancer cells has changed the paradigm for treating non-Hodgkin’s lymphomas...

Full description

Bibliographic Details
Main Authors: Wassim Mchayleh, Prabhjot Bedi, Rajesh Sehgal, Melhem Solh
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/2/207